TRANS GENIC GROUP INC.

As of March 31, 2026, TRANS GENIC GROUP INC. carries a market capitalization of 4.26B, placing it among publicly traded companies globally. Its enterprise value stands at 4.28B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

TRANS GENIC GROUP INC.'s next confirmed earnings release is scheduled for November 12, 2026.

As of March 31, 2026, TRANS GENIC GROUP INC. has 16.65M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, TRANS GENIC GROUP INC. maintains a current ratio of 1.74, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, TRANS GENIC GROUP INC.'s stock has gained approximately 1.47% over the past 52 weeks. The 50-day moving average sits at 244.68, while the 200-day moving average is 255.96.

As of March 31, 2026, TRANS GENIC GROUP INC. holds 2.13B in cash and equivalents against 2.09B in total debt, resulting in a net debt position of -46.05M. Total book value stands at 4.78B, with working capital of 2.86B providing operational flexibility.

TRANS GENIC GROUP INC.'s most recent stock split took place on March 27, 2013 with a 1:100 split ratio.